Lamia Azzi-Martin

Lamia Azzi-Martin

Auto-generated profile, based on publicly available information

Lamia Azzi-Martin

Université de Bordeaux, Inserm, BRIC-Bordeaux Institute of Oncology, U1312 , Bordeaux

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 January 2015 in Journal of Experimental Botany
Verified
Journal Article
Open access
PDF file
LALamia Azzi
Lamia Azzi
CDCynthia Deluche
Cynthia Deluche
FGFrédéric Gévaudant
Frédéric Gévaudant
NFNathalie Frangne
Nathalie Frangne
FDFrederic Delmas
Frederic Delmas
CCChristian Chevalier
Christian Chevalier
Tomato (Solanum lycopersicum Mill.) represents a model species for all fleshy fruits due to its biological cycle and the availability of numerous genetic and molecular resources. Its importance in human nutrition has made it one of the most valuable worldwide commodities. Tomato fruit size results from the combination of cell number and cell size, which are determined by both cell division and expansion. As fruit growth is mainly driven by cell expansion, cells from the (fleshy) pericarp tissue become highly polyploid according to the endoreduplication process, reaching a DNA content rarely encountered in other plant species (between 2C and 512C). Both cell division and cell expansion are under the control of complex interactions between hormone signalling and carbon partitioning, which establish crucial determinants of the quality of ripe fruit, such as the final size, weight, and shape, and organoleptic and nutritional traits. This review describes the genes known to contribute to fruit growth in tomato.

1 April 2016 in Oncotarget
Verified
Journal Article
Open access
PDF file
BCBenjamin Le Calvé
Benjamin Le Calvé
AGAudrey Griveau
Audrey Griveau
DVDavid Vindrieux
David Vindrieux
RMRaphaël Maréchal
Raphaël Maréchal
CWClotilde Wiel
Clotilde Wiel
DBDavid Bernard
David Bernard
Lysyl oxidase family activity promotes resistance of pancreatic ductal adenocarcinoma to chemotherapy by limiting the intratumoral anticancer drug distribution

1 November 2022 in Seminars in Cancer Biology
Verified
Journal Article
Closed access
CVChristine Varon
Christine Varon
LALamia Azzi-Martin
Lamia Azzi-Martin
SKSadia Khalid
Sadia Khalid
LSLornella Seeneevassen
Lornella Seeneevassen
AMArmelle Ménard
Armelle Ménard
PSPirjo Spuul
Pirjo Spuul

15 May 2017 in Journal of Cell Science
Verified
Journal Article
Open access
PDF file
FSFrédéric Saltel
Frédéric Saltel
AGAlban Giese
Alban Giese
LALamia Azzi
Lamia Azzi
HEHabiba Elatmani
Habiba Elatmani
PCPierre Costet
Pierre Costet
HJHélène Jacquemin-Sablon
Hélène Jacquemin-Sablon
Unr (officially known as CSDE1) is a cytoplasmic RNA-binding protein with roles in the regulation of mRNA stability and translation. In this study, we identified a novel function for Unr, which acts as a positive regulator of placental development. Unr expression studies in the developing placenta revealed the presence of Unr-rich foci that are apparently located in the nuclei of trophoblast giant cells (TGCs). We determined that what we initially thought to be foci, were actually cross sections of a network of double-wall nuclear membrane invaginations that contain a cytoplasmic core related to the nucleoplasmic reticulum (NR). We named them, accordingly, Unr-NRs. Unr-NRs constitute a novel type of NR because they contain high levels of poly(A) RNA and translation factors, and are sites of active translation. In murine tissues, Unr-NRs are only found in two polyploid cell types, in TGCs and hepatocytes. In vitro, their formation is linked to stress and polyploidy because, in three cancer cell lines, cytotoxic drugs that are known to promote polyploidization induce their formation. Finally, we show that Unr is required in vivo for the formation of Unr-containing NRs because these structures are absent in Unr-null TGCs.

1 July 2019 in Stem Cell Research
Verified
Journal Article
Open access
JEJulie Estève
Julie Estève
JBJean-Marc Blouin
Jean-Marc Blouin
MLMagalie Lalanne
Magalie Lalanne
LALamia Azzi-Martin
Lamia Azzi-Martin
PDPierre Roger Dubus
Pierre Roger Dubus
EREmmanuel Richard
Emmanuel Richard
Primary hyperoxaluria type 1 (PH1) is a rare autosomal recessive disorder of the liver metabolism due to functional deficiency of the peroxisomal enzyme alanine:glyoxylate aminotransferase (AGT). AGT deficiency results in overproduction of oxalate which complexes with calcium to form insoluble calcium-oxalate salts in urinary tracts, ultimately leading to end-stage renal disease. Currently, the only curative treatment for PH1 is combined liver-kidney transplantation, which is limited by donor organ shortage and lifelong requirement for immunosuppression. Transplantation of genetically modified autologous hepatocytes is an attractive therapeutic option for PH1. However, the use of fresh primary hepatocytes suffers from limitations such as organ availability, insufficient cell proliferation, loss of function, and the risk of immune rejection. We developed patient-specific induced pluripotent stem cells (PH1-iPSCs) free of reprogramming factors as a source of renewable and genetically defined autologous PH1-hepatocytes. We then investigated additive gene therapy using a lentiviral vector encoding wild-type AGT under the control of the liver-specific transthyretin promoter. Genetically modified PH1-iPSCs successfully provided hepatocyte-like cells (HLCs) that exhibited significant AGT expression at both RNA and protein levels after liver-specific differentiation process. These results pave the way for cell-based therapy of PH1 by transplantation of genetically modified autologous HLCs derived from patient-specific iPSCs.

4 March 2021 in PLOS Pathogens
Verified
Journal Article
Open access
PDF file
WHWencan He
Wencan He
LALamia Azzi-Martin
Lamia Azzi-Martin
VVValérie Velasco
Valérie Velasco
Philippe LehoursPhilippe Lehours
Philippe Lehours
PDPierre Dubus
Pierre Dubus
AMArmelle Ménard
Armelle Ménard
Humans are frequently exposed to bacterial genotoxins of the gut microbiota, such as colibactin and cytolethal distending toxin (CDT). In the present study, whole genome microarray-based identification of differentially expressed genes was performedin vitroon HT29 intestinal cells while following the ectopic expression of the active CdtB subunit ofHelicobacter hepaticusCDT. Microarray data showed a CdtB-dependent upregulation of transcripts involved in positive regulation of autophagy concomitant with the downregulation of transcripts involved in negative regulation of autophagy. CdtB promotes the activation of autophagy in intestinal and hepatic cell lines. Experiments with cells lacking autophagy related genes, ATG5 and ATG7 infected with CDT- and colibactin-producing bacteria revealed that autophagy protects cells against the genotoxin-induced apoptotic cell death. Autophagy induction could also be associated with nucleoplasmic reticulum (NR) formation following DNA damage induced by these bacterial genotoxins. In addition, both genotoxins promote the accumulation of the autophagic receptor P62/SQSTM1 aggregates, which colocalized with foci concentrating the RNA binding protein UNR/CSDE1. Some of these aggregates were deeply invaginated in NR in distended nuclei together or in the vicinity of UNR-rich foci. Interestingly, micronuclei-like structures and some vesicles containing chromatin and γH2AX foci were found surrounded with P62/SQSTM1 and/or the autophagosome marker LC3. This study suggests that autophagy and P62/SQSTM1 regulate the abundance of micronuclei-like structures and are involved in cell survival following the DNA damage induced by CDT and colibactin. Similar effects were observed in response to DNA damaging chemotherapeutic agents, offering new insights into the context of resistance of cancer cells to therapies inducing DNA damage.